Cinnamon (Ceylon vs Cassia)

The VerdictLOW CONVICTION

Cinnamon nudges blood sugar down in diabetics, but it is not a treatment, and most people buy the riskier kind.

Check your cinnamon jar. If it does not say "Ceylon" (or "Cinnamomum zeylanicum"), it is almost certainly cassia, the kind with about 250x more of a liver-stressing compound called coumarin. For any daily habit, switch to Ceylon or an aqueous extract. Same flavor, the only real risk removed.

It nudges fasting glucose down, but only in people who already have type 2 diabetes or metabolic problems, and the strongest review says the evidence is too weak to recommend it.
Most people get the species wrong: the cheap cassia in most supplements carries a liver-stressing compound, while safer Ceylon barely has any.

That's the general answer. Your stack is different.

Check your whole stack

Check your cinnamon jar. If it doesn't say "Ceylon" (or "Cinnamomum zeylanicum"), it's almost certainly cassia — the kind with about 250 times more of a liver-stressing compound called coumarin. For any daily habit, switch to Ceylon or an aqueous extract.

Both kinds carry the same active compounds, so you keep the (modest) benefit and drop the only real risk. Same flavor, safer jar.

Takes 30 seconds. Just read the label.

The Verdict

Cinnamon nudges blood sugar down in diabetics, but it's not a treatment, and most people buy the riskier kind.

Cinnamon is the dried inner bark of the Cinnamomum tree. There are two common types: cheap "cassia" (what's in most jars and capsules) and "Ceylon," the true cinnamon. People take it hoping to lower blood sugar, cholesterol, and weight.

Think of cinnamon like a gentle helper that nudges glucose out of your blood and into your cells, mostly by helping insulin do its job and slowing how fast a meal hits your bloodstream. The catch: if your blood sugar is already normal, there's nothing for it to nudge. And the cheap version hides a liver-stressing passenger called coumarin that the expensive version barely carries.

The verdict: It nudges fasting glucose down, but only in people who already have type 2 diabetes or metabolic problems, and the strictest review says the evidence is too weak to recommend it.
What most people get wrong: They grab the cheap cassia, which carries a liver-stressing compound, when safer Ceylon barely has any.
Start here: If you want to try it, 1 to 6 grams a day (roughly half to one and a half teaspoons) with meals, using Ceylon, never as a replacement for diabetes medication.

Best for

Adults with type 2 diabetes, prediabetes, PCOS, or metabolic syndrome who want a low-risk add-on alongside real treatment.

Skip if

You have normal blood sugar, or you're hoping to cut back or replace diabetes medication.

Want the full evidence? Keep scrolling

The Protocol

What to take, how much, and which kind. Nothing here matters as much as the species choice: Ceylon or an aqueous extract over cheap cassia.

Who	Dose	Timing	Form
Type 2 diabetes / metabolic disease (add-on)	1–6 g/day powder, or 120 mg–1 g extract	With meals	Ceylon or aqueous extract
PCOS (add-on)	~1.5 g/day (trial range)	With meals	Ceylon
Mild high blood pressure (add-on)	≤2 g/day (bigger effect at lower dose)	Daily	Ceylon
Healthy / normal blood sugar	No effective dose — culinary amounts only	—	Ceylon (cooking)

Which kind to buy

Ceylon powder

~1/250th the coumarin

The default for any daily habit. Same actives, far safer.

~£8–15/month

Aqueous extract

strips most coumarin

Concentrates the polyphenols, leaves the coumarin behind.

~£12–25/month

Cassia powder

highest coumarin load

Cheapest, but no efficacy edge and the only real risk. Avoid for daily dosing.

~£3–6/month

Essential oil

topical / antifungal only

Not a way to take cinnamon for blood sugar.

varies

How to take it: with meals, since the real effect is softening the blood-sugar spike after you eat. The active compounds are water-soluble, so a water extract captures them well. No special cofactors needed. Reassess at 12 weeks — if your fasting glucose hasn't moved, it isn't working for you.

Safety & Interactions

Coumarin in cassia (the real limit)

Coumarin is a liver-stressing compound. Europe's food safety authority sets a safe daily intake around 7 mg for a 70 kg adult. One teaspoon of cassia (about 2–3 g) can supply 7–18 mg, so supplement-range cassia can pass that limit on its own. Ceylon barely has any.

Diabetes medication (metformin, sulfonylureas, insulin)

Cinnamon can add to their glucose-lowering effect. If you stack them, watch for low blood sugar and tell your doctor.

Liver disease / heavy alcohol

Avoid high-dose, daily cassia — the coumarin adds to the liver burden.

Warfarin (often overstated)

Cinnamon's coumarin is not the blood-thinning kind. A Phase I trial of Ceylon found no blood-thinning effect. For Ceylon, this interaction is largely a myth.

Side effects are mild and uncommon: transient indigestion, mouth or lip irritation, rare allergic reactions.
Cassia liver-enzyme problems show up at the case-report level with high chronic doses, not in group trial data at normal doses.
Pregnancy: avoid supplemental doses (not enough safety data). Cooking amounts are fine.

The one number that matters

Coumarin safe daily intake: ~0.1 mg per kg of body weight (~7 mg for a 70 kg adult).

This is a cassia problem, not a cinnamon problem. Choose Ceylon and it effectively disappears.

Conviction: LOW-to-MODERATE

The glucose effect is real in direction but small, heterogeneous, surrogate-only, and unendorsed by the strictest review. The safety distinction (cassia coumarin) is the one thing here we hold with high confidence.

T2D / metabolic glucoseMODERATE (surrogate, no guideline backing)

PCOS insulin resistanceMODERATE

Blood pressure (add-on)MODERATE–LOW

Period painMODERATE–LOW

Cholesterol (general adults)LOW / NULL

Weight lossLOW (trivial)

Healthy adults, any benefitLOW

Cassia coumarin riskHIGH

What would change this verdict

A pre-registered, independent (non-industry) double-blind trial of 300+ people with type 2 diabetes, using a standardized low-coumarin Ceylon or extract at a fixed dose for at least 24 weeks, powered for HbA1c (a 0.3% or larger drop) with a real-world secondary like time-to-medication-increase, would push the diabetes verdict toward HIGH and settle the species question. A healthy-adult arm would settle whether there's anything here for people with normal blood sugar.

Worth Your Money?

Weekly cost~£2–4/week for Ceylon powder (a daily half-to-one teaspoon). Cassia is cheaper but coumarin-limited.

Worth it ifYou have type 2 diabetes, prediabetes, PCOS, or metabolic syndrome, you buy Ceylon, and you treat it as an add-on to real care.

Lower priority ifYour diet, training, and prescribed treatment aren't dialed in yet. Your first pounds buy more there than in a spice jar. And if your blood sugar is normal, there's nothing here to pay for.

Conditional Value

Go Deeper

Want to stop wasting money on supplements that don't work? The Verdict reviews one every week — free.

Get the free weekly review

Claims vs Evidence — See What the Research Found

What People Claim

"A natural blood-sugar fix. Sprinkle it on your oats or take a capsule and your glucose, cholesterol, and waistline all improve."

Cinnamon rides the same wave as berberine and apple cider vinegar — the spice-rack version of "Ozempic in a jar." Social media pushes it for weight loss and "balancing blood sugar" even in healthy people who have no blood-sugar problem to begin with. There's also a quieter, more sophisticated claim with real substance: that Ceylon ("true") cinnamon is meaningfully different from the cassia most people buy. That one is true, but for the opposite reason most people think. The difference that matters isn't efficacy. It's safety.

What the Evidence Actually Shows

Claim	Evidence	What the data shows
Lowers fasting glucose in T2D	MODERATE	Real but modest and heterogeneous (Zhou 2024, 24 RCTs; Allen 2013, FPG −24.59 mg/dL). Surrogate only.
Treats diabetes / replaces meds	DEBUNKED	Cochrane 2012 (n=577): insufficient evidence. No guideline endorses it.
Improves insulin resistance in PCOS	MODERATE	Consistent metabolic signal, small trials (Heydarpour 2020).
Lowers blood pressure	MOD–LOW	SBP −6.23 / DBP −3.93 mmHg, larger at ≤2 g (Hadi 2020, n=641).
Eases period pain	MOD–LOW	Pain reduction vs placebo (Niazi 2020, n=647).
Lowers LDL/HDL in general adults	LOW / NULL	No significant effect (Maierean 2017, n=750). Only triglycerides move, mainly in T2D.
Burns fat / weight loss	LOW	~1 kg pooled — clinically trivial (Jamali 2020, n=786).
Helps healthy people "balance blood sugar"	LOW	Nothing to move in normal glucose. Debunked by absence.

The Full Picture — Mechanism, Debate & Nuance

How It Works

Cinnamon's active compounds are water-soluble polyphenols, mainly type-A procyanidins and cinnamaldehyde. In lab and human studies they appear to help insulin do its job (better glucose uptake into muscle and fat cells) and to slow how fast the stomach empties, which softens the spike after a meal. Both Ceylon and cassia carry these actives, so efficacy is roughly a wash between species. The honest version: the human effect is genuine in direction but small, and it only shows up clearly when there's elevated glucose to bring down.

The Ceylon-versus-cassia story is about a contaminant, not the active. Cassia (cheap "baker's" cinnamon) is loaded with coumarin, which is toxic to the liver in susceptible people at high chronic doses. Ceylon ("true" cinnamon) has almost none. So the species you choose changes your risk, not your benefit. One useful trick: an aqueous (water) extract pulls out the polyphenols while leaving most of the fat-soluble coumarin behind.

The Debate

Does it work for diabetes?

Newer meta-analyses (Zhou 2024)

Significant fasting-glucose reduction in type 2 diabetes.

Cochrane review (2012, n=577)

Insufficient evidence to recommend it. No diabetes guideline endorses it.

Why they disagree: Cochrane used stricter bias rules and weighed clinical endpoints; newer reviews pool more small single-region trials reporting surrogate glucose. Heterogeneity often tops 90%, so trust the direction, not the size.

Does it lower cholesterol?

Khan 2003 + T2D reviews

Cinnamon lowers LDL and triglycerides.

Maierean 2017 + 2024 Ceylon trial

No LDL/HDL effect. Triglycerides only.

The lipid benefit is confined to dyslipidemic diabetics and to cassia water-extract trials. In healthy or Ceylon-only studies, the LDL effect vanishes. The field moved from "improves glucose and lipids" to "improves glucose; lipids inconsistent."

Honest Limitations

Species opacity

Lab studies name the cinnamon. Real jars usually just say "cinnamon" (it's usually cassia) and the buyer can't tell. The efficacy evidence and the safety evidence are stuck to different products on the same shelf.

Heterogeneity

The tidy pooled numbers come from many small, mostly non-Western trials with enormous variation. Trust the direction, not the magnitude.

Surrogate endpoints

Benefits are blood markers (glucose, HbA1c), not hard outcomes. No trial shows cinnamon reduces diabetic complications or heart events. A moved biomarker is not a treatment.

The Nuance

What doesn't work

"Cinnamon lowers cholesterol." Null for LDL/HDL in general adults. Only triglycerides move, mainly in diabetics.
"Cinnamon is a fat burner." Pooled weight loss is about 1 kg. Meaningless.
"Take cinnamon to balance your blood sugar" (said to healthy people). Nothing to move in normal glucose.
"More cinnamon is better." With cassia, more is worse — you hit the coumarin ceiling before you gain anything.

Who benefits most: adults with type 2 diabetes, prediabetes, or metabolic syndrome (MODERATE), women with PCOS-related insulin resistance (MODERATE), and people with mild high blood pressure as a minor add-on (MODERATE–LOW).

Food-first: if you want cinnamon, just cook with Ceylon. The supplement adds dose and cost, not magic. Your money does more on diet, training, and prescribed treatment.

Sources

Leach MJ, Kumar S (2012). Cinnamon for diabetes mellitus. Cochrane Database Syst Rev. 10 RCTs (n=577). Insufficient evidence to recommend.
Zhou Q, et al. (2024). Cinnamon on glycemic control in T2DM: updated dose-response meta-analysis. Phytother Res. 24 RCTs. FBS SMD −1.32; HbA1c SMD −0.67.
Allen RW, et al. (2013). Cinnamon use in type 2 diabetes: updated SR/MA. Ann Fam Med. 10 RCTs (n=543). FPG −24.59 mg/dL; HbA1c unchanged.
Maierean SM, et al. (2017). Cinnamon on blood lipid concentrations: SR/MA. J Clin Lipidol. 13 RCTs (n=750). LDL/HDL null; triglycerides reduced.
Hadi A, et al. (2020). Anti-hypertensive effects of cinnamon: dose-response MA. Crit Rev Food Sci Nutr. 9 RCTs (n=641). SBP −6.23 / DBP −3.93 mmHg.
Jamali N, et al. (2020). Cinnamon and obesity: dose-response MA. Clin Nutr. 12 RCTs (n=786). Body weight −1.02 kg (trivial).
Hajimonfarednejad M, et al. (2019). Cinnamon: a systematic review of adverse events. Coumarin hepatotoxicity and GI/allergic events catalogued.
EFSA coumarin tolerable daily intake 0.1 mg/kg/day; Herz C, et al. (2008), Food Chemistry — coumarin ~250× higher in cassia than Ceylon.